<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00227357</url>
  </required_header>
  <id_info>
    <org_study_id>1-H97HA03796-01-00</org_study_id>
    <nct_id>NCT00227357</nct_id>
  </id_info>
  <brief_title>The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration</brief_title>
  <acronym>BUP</acronym>
  <official_title>SPNS - An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Abuse Treatment in HIV Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruth M. Rothstein CORE Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health Resources and Services Administration (HRSA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>The New York Academy of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ruth M. Rothstein CORE Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to develop and evaluate an innovative model of care to better serve
      patients who are both HIV-infected and opioid-dependent.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: HIV, opioid dependent patients provided agonist therapy at the site of their
      primary care will have better retention, utilization of services, health, social and quality
      of care measures and psychiatric treatment outcomes.

      The Buprenorphine Project is an examination of two methods of service delivery. The purpose
      of this study is to assess the feasibility, cost and effectiveness of an intervention
      designed to integrate buprenorphine treatment for opioid dependence into HIV primary care at
      the CORE Center. For this project we will provide buprenorphine to 60 opioid dependent
      patients at any one time and will compare this on-site treatment group to 60 opioid dependent
      HIV+ patients who select off-site methadone or no agonist treatment at the time of
      enrollment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">101</enrollment>
  <condition>HIV Infections</condition>
  <condition>AIDS</condition>
  <condition>Opiate Dependence</condition>
  <condition>Post-Traumatic Stress Disorders</condition>
  <arm_group>
    <arm_group_label>Buprenorphine</arm_group_label>
    <description>Study patients receiving buprenorphine treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparison</arm_group_label>
    <description>Study patients receiving methadone or no agonist treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>On-site - buprenorphine/naloxone (Suboxone)</intervention_name>
    <description>Tablet, sub-lingual, 8/2 mg, 1-3 daily</description>
    <arm_group_label>Buprenorphine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Off-site - methadone or no agonist</intervention_name>
    <arm_group_label>Comparison</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients receiving buprenorphine treatment Patients not receiving buprenorphine treatment
        (methadone or none)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Patient of the CORE Center

          -  HIV-infected (confirmed by HIV assay results)

          -  Opioid-dependent (by Diagnostic and Statistical Manual of Mental Disorders, Fourth
             Edition, Text Revision [DSM-IV-TR] criteria)

          -  Fluent in English or Spanish

          -  Planning to stay in Chicago area for the next 12 months

        Exclusion Criteria:

          -  Liver function tests (LFTs) (transaminase only) at 5 times or higher than normal

          -  DSM-IV-TR criteria for benzodiazepine abuse or dependence within the past 6 months

          -  DSM-IV-TR criteria for alcohol dependence within the past 6 months or actively
             suicidal

          -  Psychiatric impairment that impedes ability to consent

          -  Methadone dose exceeds level allowing for safe transition to buprenorphine

          -  Pregnant women or women actively trying to become pregnant

          -  Clinical judgement that patient is inappropriate for medical or psychiatric reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey D. Watts, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The CORE Center and John H. Stroger, Jr. Hospital of Cook County, Affiliates of the Cook County Bureau of Health Services</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The CORE Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2005</study_first_submitted>
  <study_first_submitted_qc>September 27, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2005</study_first_posted>
  <last_update_submitted>June 4, 2010</last_update_submitted>
  <last_update_submitted_qc>June 4, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jeffrey D. Watts, M.D.</name_title>
    <organization>The Ruth M. Rothstein CORE Center</organization>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>AIDS</keyword>
  <keyword>Buprenorphine</keyword>
  <keyword>Methadone</keyword>
  <keyword>Primary care</keyword>
  <keyword>dual diagnosis</keyword>
  <keyword>ptsd</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Buprenorphine</mesh_term>
    <mesh_term>Methadone</mesh_term>
    <mesh_term>Buprenorphine, Naloxone Drug Combination</mesh_term>
    <mesh_term>Naloxone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

